Bausch+Lomb Results Presentation Deck
Path to Continue Growth Momentum in Key Franchises ¹
2
LUMIFY
Redness
Relief
Consumer
Eye
Illuminations
2023
w
BLUECK FLOWE
BAUSCH+ LOMB
LUMIFY
PRESERVATIVE FRO
F
I
2024
Lumify
+47% reported revenue
growth in 3Q23 vs. 3Q22
GABRIE
LUMIFY
ALLERGY
HENTITORY P
WEERDVIGYE
PEUSELARL
Bourd
Impetiin
200 13 ERVIN
Preservative Allergy
Free
Symptoms
are
Launched Lumify Eye Illuminations™
specialty eye care line in 3Q23
Contact Lenses
SAUSERFIONE
INFUSE
1. See Slide 1 for further information on forward-looking statements.
ULTRA
Daily SiHy
SVS
2023
INFUSE
ULTRA
Daily SiHy
Multifocal
BAUSCHYLOME
INFUSE
ULTRA
Daily SiHy
Toric
2024
w
Daily SiHy
+79% reported revenue
growth in 3Q23 vs. 3Q22
Launched Multifocal in U.S.
and SVS in China in 2Q23
MULTING
enVistatoric
LUXSMART™
by Bausch Lomb
138
Apthera.
OL
2023
Surgical
enVista LUX
ASPIRE
BILA:YATLA
Extended
Range
enVista enVista
mone uits ou Pan
EDOF
ENVY
LuxLife
Trifocal
Trifocal
2024
Premium 1OLS
+44% reported revenue
growth in 3Q23 vs. 3Q22
Continuing to expand portfolio with
newly launched enVista Aspire ™
17View entire presentation